Intrinsiqs

Is Bright Minds Biosciences Inc. overvalued?

Bright Minds Biosciences Inc. (DRUG) — key valuation metrics and fundamentals.

No verdict
Price
$72.81
Fair value
Current P/E
Normal P/E
Market cap
$701.7M
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares DRUG's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jul 2026.